Active ingredients: clarithromycin
What it is used for
For use in adults and children older than 12 years for the treatment of mild to moderately severe infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Acute streptococcal pharyngitis. Community acquired pneumonia due to Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia and Strep. pneumoniae. Uncomplicated skin and skin structure infections due to Staph. aureus or Strep. pyogenes. Disseminated or localised mycobacterial infections due to M. avium or M. intracellulare and skin and skin structure infections due to M. chelonae. Clarithromycin should be used in combination with other antimycobacterial agents. Prevention of disseminated M. avium complex infection in HIV infected adults with CD4 lymphocyte counts < 75 cells/mm3. Disseminated infection due to M. avium complex should be excluded by a negative blood culture prior to commencement of prophylaxis. Acute bacterial exacerbation of chronic bronchitis due to H. influenzae, Moraxella catarrhalis or Strep. pneumoniae. Combination therapy for the treatment of peptic ulcer disease associated with H. pylori infection. For use in children for the treatment of mild to moderately severe infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Acute streptococcal pharyngitis and tonsillitis caused by Strep. pyogenes. Community acquired pneumonia including infections due to Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophilia. Skin and skin structure infections (e.g. impetigo). Disseminated or localised infections due to M. avium or M. intracellulare in immunocompromised children, including those with HIV infection or AIDS. Acute otitis media. Note. Penicillins are the drug of first choice in the treatment of acute otitis media. Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections including prophylaxis of rheumatic fever. Clarithromycin appears to be as effective as phenoxymethylpenicillin in the eradication of Streptococci from the nasopharynx, however substantial data establishing the efficacy of Clarithromycin in the subsequent prevention of rheumatic fever are not available at present. There is insufficient evidence of efficacy to support the use of Clarithromycin in acute bronchitis in young children. The data presented on infections of skin and skin structure were confined largely to mild to moderate infections such as impetigo.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Yellow, oval film-coated tablet 7.8mm x 14.9mm
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient clarithromycin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.